ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Predicted Indirectly Recognizable H L A Epitopes Are Associated with T-cell Mediated Rejection among Kidney Transplant Recipients with Preformed and De Novo Donor-Reactive T-cells

T. Schachtner1, M. Stein2, N. M. Otto3, P. M. Reinke2

1Nephrology, University Hospital Zurich, Zurich, Switzerland, 2Berlin-Brandenburg Center for Regenerative Therapies, Charite University Medicine Berlin, Berlin, Germany, 3Berlin-Brandenburg Center for Regenerative Therapies, Charite University Medicine Berlin, Berin, Germany

Meeting: 2019 American Transplant Congress

Abstract number: 427

Keywords: Allorecognition, Epitopes, Histocompatibility antigens, T cell reactivity

Session Information

Session Name: Concurrent Session: Kidney: Acute Cellular Rejection

Session Type: Concurrent Session

Date: Tuesday, June 4, 2019

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:06pm-3:18pm

Location: Ballroom C

*Purpose: Very recently Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) have been suggested to demonstrate early and late effects on kidney allograft outcomes. The association between PIRCHE scoring and donor-reactive T-cells, that have been related to an increased risk of T-cell mediated rejection (TCMR), however, hasn’t been studied and may provide a link for those findings.

*Methods: We analyzed 331 kidney transplant recipients (KTRs) of a first allograft between 2008 and 2015 in our transplant center at Charité Campus Virchow Clinic. KTRs were grouped with respect to preformed donor-reactive T-cells and the development of de-novo donor-reactive T-cells. Samples were collected pretransplantation, at +1, +2, and +3 months posttransplantation. Donor-reactive T-cells were measured by interferon-γ Elispot assay. HLA epitope mismatches were determined by the PIRCHE approach and PIRCHE scores by recipient HLA class I (PIRCHE-I) and HLA class II (PIRCHE-II) were assessed.

*Results: Among 331 KTRs, 108 KTRs (33%) showed preformed donor-reactive T-cells, and among 223 KTRs without preformed donor-reactive T-cells, 35 KTRs (16%) developed de-novo donor-reactive T-cells. PIRCHE-I and -II scores weren’t associated with the presence of preformed or development of de-novo donor-reactive T-cells (p>0.05). Among 108 KTRs with preformed donor-reactive T-cells, 16 of 40 KTRs (40.0%) with PIRCHE-II score >30 developed TCMR within the first posttranplant year, whereas only 7 of 68 KTRs (10.3%) with PIRCHE-II score <30 developed TCMR (p<0.001). Among 35 KTRs with development of de-novo donor-reactive T-cells, 6 of 13 KTRs (46.2%) with PIRCHE-II score >30 developed TCMR within the first posttranplant year, whereas only 1 of 22 KTRs (4.5%) with PIRCHE-II score <30 developed TCMR (p<0.001). 24 of 188 KTRs (12.8%) without donor-reactive T-cells developed TCMR within the first posttransplant year, that were not associated with PIRCHE-II scores (p=0.587). Among KTRs with donor-reactive T-cells the development of de-novo donor-specific antibodies was independent of PIRCHE-II scores (p=0.409). Among KTRs without donor-reactive T-cells the development of de-novo donor-specific antibodies showed a tendency for higher PIRCHE-II scores (p=0.077).

*Conclusions: PIRCHE didn’t impact the presence of preformed or development of de-novo donor-reactive T-cells. In KTRs with donor-reactive T-cells, PIRCHE-II scores impact the development of TCMR. PIRCHE scores in the absence of donor-reactive T-cells didn’t impact the development of TCMR. The combination of donor-reactive T-cells with PIRCHE scores may allow improved risk stratification with respect to the development of TCMR, whereas PIRCHE scores alone provide limited use.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Schachtner T, Stein M, Otto NM, Reinke PM. Predicted Indirectly Recognizable H L A Epitopes Are Associated with T-cell Mediated Rejection among Kidney Transplant Recipients with Preformed and De Novo Donor-Reactive T-cells [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/predicted-indirectly-recognizable-h-l-a-epitopes-are-associated-with-t-cell-mediated-rejection-among-kidney-transplant-recipients-with-preformed-and-de-novo-donor-reactive-t-cells/. Accessed May 9, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences